THE REACTA FORUM 2019 REGIONAL ASIAN CLINICAL TRIAL ANNUAL FORUM

Poster DownloadEnglish
Poster Download日本語
CCRC
Chiba University Hospital
Clinical Research Center
The REACTA Forum 2019
Registration Secretariat
c/o JTB Communication
Design, Inc.
Celestine Shiba Mitsui Bldg.
3-23-1 Shiba, Minato-ku,
Tokyo 105-8335, Japan
Tel: +81-3-5657-0708
E-mail: reacta2019@jtbcom.co.jp

Program※Program will be updated shortly

Opening Remarks8:25-8:30

Key note address8:30-9:00

Challenges and Opportunities in Clinical Research in East Asia
 
Hiromichi Shirasawa
(MSD K.K.)
 
白沢 博満
(MSD株式会社)

Session 19:00-10:40

Innovative Approaches for Clinical Trials
Recent advances in digital technology and future of “data-driven healthcare”
 
Takayuki Sasaki
(Office of Pharmaceutical Industry Research)
 
佐々木 隆之
(日本製薬工業協会 医薬産業政策研究所)
Values of Digital and RWD for Clinical Trials: Views from Pharma companies
 
Shinya Suda
(Astellas Pharma Inc.)
 
須田 真也
(アステラス製薬株式会社)
Learnings from a virtual trial pilot in the US
 
Yumiko Miyazaki
(Eli Lilly Japan K.K.)
 
宮崎 由美子
(日本イーライリリー株式会社)
Engaging patients in Asia for clinical trials – the secret to success
 
David Yoshii
(Parexel International Corporation)
AI-Enhanced Safety of Prescriptions and Clinical Application
 
Alex Nguyen
(Taipei Medical University)

- Coffee Break (10:40-10:50)

Session 210:50-12:30

Regenerative Medicine
Current topics in Regenerative Medical Products
 
Yasuhiro Fujiwara
(Pharmaceuticals and Medical device Agency
 Office of Cellular and Tissue-based Products)
 
藤原 康宏
(医薬品医療機器総合機構 再生医療製品等審査部)
Regenerative medicine: Developments and market outlook in Japan
 
Sonoko Shiokawa
(Seed Planning, Inc.)
 
塩川 園子
(株式会社 シード・プランニング)
Paradigm shift of medical care by a novel reparative therapy with Muse cell
 
Seiichi Kiso
(Life Science Institute, Inc.)
 
木曽 誠一
(株式会社 生命科学インスティテュート)
Cancer immunotherapy - from basic research of NKT cell to clinical fields-
 
Shinichiro Motohashi
(Chiba University)
 
本橋 新一郎
(千葉大学)
Malaysia's Clinical Trial Guideline on Cell and Cell-based Therapies
 
Fadilah Abdul Wahid
(The National University of Malaysia)

- Lunch (12:30-14:00)

Session 314:00-15:20

Clinical Development / Pharmaceutical Strategy in Asia
Clinical development strategy to maximize the potential of Asia in global study
 
Koichi Miyazaki
(Daiichi Sankyo Co., Ltd.,)
 
宮崎 浩一
(第一三共株式会社)
Key consideration of regulation for Asian clinical development
 
Yuko Kikuchi
(Eisai Co., Ltd.,)
 
菊地 裕子
(エーザイ株式会社)
Investigational Drug Products for Phase 1 Studies
– Clinical Development Efficiencies through Best Practice Pharmacy Compounding
 
Kate Reese
(Celerion Inc.)
(about: ICH E17)
 
Yoshiaki Uyama
(Pharmaceuticals and Medical Device Agency / Chiba University)
 
宇山 佳明
(医薬品医療機器総合機構 / 千葉大学)

- Coffee Break (15:20-15:30)

Session 415:30-16:50

Clinical Trials in Asia
Kawasaki Disease and KAICA Trial
 
Hiromichi Hamada
(Tokyo Woman’s Medical University)
 
濱田 洋通
(東京女子医科大学)
Current Issues about Immunologic agent clinical trials in Korea
 
Sung Yong Oh
(Dong-A University)
Medical Device trials in Malaysia – New opportunities
 
Alvin Lee
(InnoSignum SDN. BHD.)
Comparison of urinary tract infection in Asian countries
 
Katsumi Shigemura
(Kobe University)
 
重村 克巳
(神戸大学)

Session 516:50-18:10

Academic Research Organization's Initiatives
South Korea's Clinical Trial Infrastructure: Lessons learned and the way forward
 
Anthony Nguyen
(Dong-A University)
The Special ARO System Infrastructure of TMU to Support Pharmaceutical Industry
 
Shian-Ying Sung
(Taipei Medical University)
Collaboration between academia, industry and the government to catalyse clinical research in Malaysia
 
Audrey Ooi
(Clinical Research Malaysia)
Chiba university ARO initiative and the education of academia clinical research professional staff
 
Hideki Hanaoka
(Chiba University)
 
花岡 英紀
(千葉大学)

Closing Remarks18:10-18:15

ページトップへ戻る